Newtricious, an Oirlo, Limburg, The Netherlands-based life sciences company, has raised a funding of undisclosed amount from a consortium of investors.
Backers include Jan van der Hoeven, founder and CEO of Brabant Life Sciences Seed Fund (BLSF).
The company intends to use the funding to continue to develop its first products focusing on the maintenance of health in people at risk for chronic diseases such as macular degeneration and cardiovascular illnesses.
Newtricious was founded in 2006 by CEO Jos Nelissen.
FinSMEs
17/01/2012